Erratum: Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome (JAMA (2017) 318:19 (1913-1924) DOI: 10.1001/jama.2017.17488);Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome

JAMA - Journal of the American Medical Association

Volumn 318, Issue 19, 2017, Pages 1913-1924

  Chapman, Andrew R ^a   Lee, Kuan Ken ^a   McAllister, David A ^b   Cullen, Louise ^c,d,e   Greenslade, Jaimi H ^c,d,e   Parsonage, William ^c,d,e   Worster, Andrew ^f   Kavsak, Peter A ^f   Blankenberg, Stefan ^g   Neumann, Johannes ^g   Söerensen, Nils A ^g   Westermann, Dirk ^g   Buijs, Madelon M ^h   Verdel, Gerard J E ⁱ   Pickering, John W ^j,k   Than, Martin P ^k   Twerenbold, Raphael ^l   Badertscher, Patrick ^l   Sabti, Zaid ^l   Mueller, Christian ^l   Anand, Atul ^a   Adamson, Philip ^a   Strachan, Fiona E ^a   Ferry, Amy ^a   Sandeman, Dennis ^a   Gray, Alasdair ^a,m   Body, Richard ⁿ   Keevil, Brian ⁿ   Carlton, Edward ^o   Greaves, Kim ^p   Korley, Frederick K ^q   Metkus, Thomas S ^r   Sandoval, Yader ^s   Apple, Fred S ^t   Newby, David E ^a   Shah, Anoop S V ^a   Mills, Nicholas L ^a   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY HEART CENTER HAMBURG   (Germany)

^h Atalmedial Diagnostic Center   (Netherlands)

ⁱ N   (Netherlands)

^j UNIVERSITY OF OTAGO   (New Zealand)

^k CHRISTCHURCH HOSPITAL   (New Zealand)

^l UNIVERSITY HOSPITAL BASEL   (Switzerland)

^m ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

ⁿ MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^o SOUTHMEAD HOSPITAL   (United Kingdom)

^p UNIVERSITY OF THE SUNSHINE COAST   (Australia)

^q UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^r JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^t UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL OUTCOME; HEART DEATH; HEART INFARCTION; HUMAN; LONG TERM CARE; LOW RISK POPULATION; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; SYSTEMATIC REVIEW; ADULT; BLOOD; DEATH; MALE; META ANALYSIS; MORTALITY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT;

ACUTE CORONARY SYNDROME; ADULT; BIOMARKERS; DEATH; HUMANS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; TROPONIN I;

EID: 85036587588     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.2159     Document Type: Erratum

References (40)

1. Makam AN, Nguyen OK. Use of cardiac biomarker testing in the emergency department. JAMA Intern Med. 2015;175(1):67-75.
2. Goodacre S, Cross E, Arnold J, Angelini K, Capewell S, Nicholl J. The health care burden of acute chest pain. Heart. 2005;91(2):229-230.
3. Goodacre S, Thokala P, Carroll C, et al. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome. Health Technol Assess. 2013;17(1):v-vi, 1-188.
4. Skinner JS, Smeeth L, Kendall JM, Adams PC, Timmis A; Chest Pain Guideline Development Group. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. Heart. 2010;96(12): 974-978.
5. Roffi M, Patrono C, Collet J-P, et al; Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016; 37(3):267-315.
6. Shah AS, Anand A, Sandoval Y, et al; High-STEACS Investigators. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet. 2015;386(10012):2481-2488.
7. Chapman AR, Anand A, Boeddinghaus J, et al. Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction. Circulation. 2017;135(17):1586-1596.
8. Carlton E, Greenslade J, Cullen L, et al. Evaluation of high-sensitivity cardiac troponin I levels in patients with suspected acute coronary syndrome. JAMA Cardiol. 2016;1(4):405-412.
9. Neumann JT, Sörensen NA, Ojeda F, et al. Immediate rule-out of acute myocardial infarction using electrocardiogram and baseline high-sensitivity troponin I. Clin Chem. 2017;63(1): 394-402.
10. Sandoval Y, Smith SW, Love SA, Sexter A, Schulz K, Apple FS. Single high-sensitivity cardiac troponin I to rule out acute myocardial infarction. Am J Med. 2017;130(9):1076-1083.e1.
11. Goorden SMI, van Engelen RA, Wong LSM, van der Ploeg T, Verdel GJ, Buijs MM. A novel troponin I rule-out value below the upper reference limit for acute myocardial infarction. Heart. 2016; 102(21):1721-1727.
12. Stewart LA, Clarke M, Rovers M, et al; PRISMA-IPD Development Group. Preferred Reporting Items for Systematic Review and Meta-analyses of Individual Participant Data: the PRISMA-IPD statement. JAMA. 2015;313(16):1657-1665.
13. Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Stat Sci. 2001; 16:101-133.
14. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
15. Wildi K, Gimenez MR, Twerenbold R, et al. Misdiagnosis of myocardial infarction related to limitations of the current regulatory approach to define clinical decision values for cardiac troponin. Circulation. 2015;131(23):2032-2040.
16. Than M, Herbert M, Flaws D, et al. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the emergency department? a clinical survey. Int J Cardiol. 2013;166(3):752-754.
17. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3): 1-48.
18. Shortt C, Ma J, Clayton N, et al. Rule-in and rule-out of myocardial infarction using cardiac troponin and glycemic biomarkers in patients with symptoms suggestive of acute coronary syndrome. Clin Chem. 2017;63(1):403-414.
19. Shah AS, Griffiths M, Lee KK, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ. 2015;350:g7873.
20. Pickering JW, Greenslade JH, Cullen L, et al. Assessment of the European Society of Cardiology 0-hour/1-hour algorithm to rule-out and rule-in acute myocardial infarction. Circulation. 2016;134 (20):1532-1541.
21. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA. 2011;306(24): 2684-2693.
22. Than M, Cullen L, Aldous S, et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol. 2012;59(23):2091-2098.
23. Cullen L, Greenslade J, Hawkins T, et al. Improved Assessment of Chest Pain Trial (IMPACT): assessing patients with possible acute coronary syndromes. Med J Aust. 2017;207(5):195-200.
24. Korley FK, Schulman SP, Sokoll LJ, et al. Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance. Acad Emerg Med. 2014;21 (7):727-735.
25. Parsonage WA, Mueller C, Greenslade JH, et al. Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests. Heart. 2016;102(16):1279-1286.
26. Than M, Aldous S, Lord SJ, et al. A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Intern Med. 2014;174(1):51-58.
27. Kavsak PA, Worster A, You JJ, et al. Ninety-minute vs 3-h performance of high-sensitivity cardiac troponin assays for predicting hospitalization for acute coronary syndrome. Clin Chem. 2013;59(9):1407-1410.
28. Body R, Cook G, Burrows G, Carley S, Lewis PS. Can emergency physicians “rule in” and “rule out” acute myocardial infarction with clinical judgement? Emerg Med J. 2014;31(11):872-876.
29. Body R, Carlton E, Sperrin M, et al. Troponin-Only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts. Emerg Med J. 2017;34(6):349-356.
30. Wildi K, Nelles B, Twerenbold R, et al. Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction. Am Heart J. 2016;181: 16-25.
31. Zhelev Z, Hyde C, Youngman E, et al. Diagnostic accuracy of single baseline measurement of Elecsys troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis. BMJ. 2015;350:h15.
32. Pickering JW, Than MP, Cullen L, et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis. Ann Intern Med. 2017;166(10):715-724.
33. Lyon AW, Kavsak PA, Lyon OA, Worster A, Lyon ME. Simulation models of misclassification error for single thresholds of high-sensitivity cardiac troponin I due to assay bias and imprecision. Clin Chem. 2017;63(2):585-592.
34. Kavsak PA, Hill SA, McQueen MJ, Devereaux PJ. Implications of adjustment of high-sensitivity cardiac troponin T assay. Clin Chem. 2013;59(3): 574-576.
35. Shah AS, McAllister DA, Mills R, et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med. 2015;128(5):493-501.e3.
36. Sandoval Y, Thordsen SE, Smith SW, et al. Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. Eur Heart J Acute Cardiovasc Care. 2014;3(4): 317-325.
37. Chapman AR, Adamson PD, Mills NL. Assessment and classification of patients with myocardial injury and infarction in clinical practice. Heart. 2017;103(1):10-18.
38. Kavsak PA, Jaffe AS, Greene DN, Christenson RH, Apple FS, Wu AHB. Total analytic error for low cardiac troponin concentrations (10 ng/L) by use of a high-sensitivity cardiac troponin assay. Clin Chem. 2017;63(5):1043-1045.
39. Collinson P, Hammerer-Lercher A, Suvisaari J, et al; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine. How well do laboratories adhere to recommended clinical guidelines for the management of myocardial infarction? the Cardiac Marker Guidelines Uptake in Europe Study (CARMAGUE). Clin Chem. 2016;62(9):1264-1271.
40. Pickering JW, Greenslade JH, Cullen L, et al. Validation of presentation and 3-h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction. Heart. 2016;102(16):1270-1278.